查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198735

動物麻醉市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Veterinary Anesthesia Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

動物麻醉市場預計在預測期內的複合年增長率為 6.5%。

主要亮點

  • COVID-19 大流行擾亂了多個國家/地區的獸醫設備供應鏈，這主要是由於生產基地暫時關閉、出口禁令以及對治療 COVID-19 的藥物的需求增加。獸醫手術的中斷和取消影響了動物麻醉市場。
  • 例如，根據 2021 年 2 月發表的一篇文章，墨西哥在 COVID-19 大流行期間經歷了獸醫服務需求和寵物診所就診量的下降，影響了動物麻醉市場的增長。據說 然而，隨著限制的解除和寵物診所服務的重新開放，市場正在復蘇。
  • 此外，與外科手術相關的慢性病的增加以及動物麻醉技術的進步對所調查市場的增長產生了積極影響。
  • 近年來，關節炎、慢性腎病、肝炎、皮膚過敏（特應性）、糖尿病、庫欣病、艾迪生病、炎症性腸病、甲亢（貓）、甲減（犬）等慢性病的流行越來越明顯。 因此，隨著這些疾病的高患病率，預計在預測期內手術數量將會增加。
  • 根據 Frontiers of Veterinary Science 報告的數據，2021 年西班牙狗的肥胖和肥胖相關代謝功能障礙 (ORMD)（例如高血壓和空腹高甘油三酯血症/高膽固醇血症）的患病率分別為 40.9% 和 20.4%。 由於狗的肥胖率很高，需要麻醉的外科手術的增加預計將促進市場的增長。
  • 此外，根據 2021 年 7 月發表在《動物科學雜誌》上的一篇論文，北美每年約有 20% 的成年犬患有骨關節炎 (OA)，超過 90% 的 20 歲以上犬隻患有骨關節炎 (OA) 5. 已報告受影響。 這種疾病的高負擔需要在手術過程中使用麻醉，這推動了市場增長。
  • 主要市場參與者採取的戰略舉措（例如產品發布、批准和合作夥伴關係）正在推動市場增長。 例如，2021年4月，深圳邁瑞動物醫療科技推出了一款名為Veta 5或Veta 3的新型動物麻醉設備。 此類產品的推出有望推動市場增長。
  • 但是，麻醉機的高成本可能會阻礙市場增長。

獸用麻醉市場趨勢

預計在預測期內伴□□侶動物部分將佔據重要的市場份額

  • 由於慢性病的增加、寵物擁有量的增加以及全球寵物保險的增加，預計伴侶動物部分將佔據重要的市場份額。
  • 根據病態動物人民藥房 (PDSA) 2021 年 6 月的動物福利報告，2020 年 3 月至 2021 年 5 月期間，英國有 200 萬人收養了寵物。 這些寵物中，10%是狗，8%是貓，13%是兔子。 根據 Der Deutsche Heimtiermarkt 的數據，到 2021 年，德國 47% 的家庭將養寵物。
  • 此外，全國寵物（包括觀賞鳥類和小動物、狗和貓）的數量達到了 3470 萬隻。 1670 萬隻貓生活在 26% 的德國家庭中，而 1030 萬隻狗生活在 21% 的家庭中，這表明德國收養的貓多於狗。我是。 由於每個國家的寵物主人和人口眾多，對動物保健的關注度越來越高。 因此，正在進行更多的獸醫診斷，增加了治療慢性病所需的麻醉需求，擴大了市場。
  • 此外，根據美國寵物用品協會 (APPA) 的數據，預計 2021 年美國將在寵物上花費約 1096 億美元，比上一年增長約 6%。 此外，隨著該地區寵物擁有量的增加，越來越多的人不得不關注寵物保險的可用性。 結果，寵物主人在寵物保健上花錢。 這開啟了創造和利用先進有效的麻醉來有效治療動物的可能性，並有望在未來幾年推動市場增長。
  • 此外，主要參與者採取的戰略舉措（例如產品發布和批准）推動了該細分市場的增長。 例如，2022 年 1 月，Decra Pharmaceuticals 收購了用於動物手術的 Halocarbon Life Sciences 的 Isoflurane USP Inhalant Anesthetic 和 Sevoflurane USP Inhalant 吸入麻醉溶液。 這些發展預計將推動這一領域的增長。

預計在預測期內，北美將佔據重要的市場份額。

  • 由於動物健康意識的提高和不斷的創新，預計北美將在動物麻醉市場佔有重要份額。
  • 隨著寵物保險在該地區的增長，預計市場增長將會擴大。 例如，根據保險信息研究所發布的 2022 年統計數據，到 2021 年底，美國將有 390 萬隻寵物投保，比 2020 年增長 20%。 我們還發現，2021 年寵物保險覆蓋率最高的三個州是加利福尼亞州 (19.3%)、紐約州 (8.4%) 和佛羅裡達州 (6.1%)。
  • 到 2021 年底，加拿大有 432,533 隻寵物投保，比 2020 年增長 22.7%。 2021年，寵物保險覆蓋率最高的三個省份分別是安大略省（38.9%）、不列顛哥倫比亞省（20.3%）和艾伯塔省（18.9%）。 該地區寵物保險訂戶數量的增加也有望推動市場增長。
  • 此外，各種市場參與者為開發有效的動物麻醉而開展的研發活動、產品發布、批准和合作預計將促進市場增長。 例如，2022 年 4 月，Respirair Global 與 Decra US 合作開發異氟醚和七氟醚獸用汽化器和麻醉配件。 該合作夥伴關係旨在擴大獸醫麻醉並開發技術先進的產品。 在分析期間，此類新興市場的發展預計將推動該地區的市場增長。

動物麻醉市場競爭者分析

由於許多公司在全球和區域開展業務，因此動物麻醉市場本質上是分散的。 競爭格局包括對少數擁有主要或重要市場份額的國際和本地公司的分析。 主要公司包括 JD Medical Dist. Co. Inc.、Kent Scientific Corporation、Midmark Corporation、Mindray Medical International Limited、Patterson Scientific、ICU Medical, Inc.、Supera Anesthesia Innovations、Tecnologia Veterinaria y Medica, S.L、Dispomed Ltd.，製造商包括DRE Veterinary、Vetland Medical Sales & Services, LLC、Avante Health Solutions、Prunus Medical 和 Dispomed Ltd. 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 慢性病和相關外科手術的增加
    • 動物麻醉的技術進步
  • 市場製約因素
    • 麻醉機成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 電車
    • 牆型
    • 桌面
  • 按動物分類
    • 同伴
    • 牲畜
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 世界其他地方

第六章競爭格局

  • 公司簡介
    • JD Medical Dist. Co. Inc.
    • Kent Scientific Corporation
    • Midmark Corporation
    • Mindray Medical International Limited
    • Patterson Scientific
    • ICU Medical, Inc.
    • Supera Anesthesia Innovations
    • Tecnologia Veterinaria y Medica, S.L
    • Vetland Medical Sales & Services, LLC
    • Avante Health Solutions
    • Dispomed Ltd.
    • Prunus Medical

第7章 市場機會與今後動向

簡介目錄
Product Code: 64155

The veterinary anesthesia market is expected to register aCAGR of 6.5% during the forecast period.

Key Highlights

  • The COVID-19 pandemic impacted the veterinary anesthesia market owing to the disruptions in the veterinary medical devices supply chain and cancellations of veterinary surgical procedures in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19.
  • For instance, according to an article published in February 2021, the demand for veterinary services and visits to pet clinics reduced in Mexico during the COVID-19 pandemic, thus impacting the growth of the veterinary anesthesia market. However, the market recovered since the restrictions were lifted and pet clinic services resumed.
  • In addition, the rising chronic diseases associated with surgical procedures and technological advancements in veterinary anesthesia are actively affecting the growth of the studied market.
  • The recent years have observed a significant rise in the prevalence of veterinary chronic diseases, such as arthritis, chronic kidney disease, hepatitis, skin allergies (atopy), diabetes mellitus, Cushing's and Addison's disease, inflammatory bowel disease, hyperthyroidism (cats) and hypothyroidism (dogs), and many others. Hence, with the high prevalence of these diseases, the number of surgical procedures is expected to rise during the forecast period.
  • According to the data reported by Frontiers of Veterinary Science, the prevalence of canine obesity and obesity-related metabolic dysfunction (ORMD), such as hypertension and fasting hypertriglyceridemia/hypercholesterolemia, was reported to be 40.9% and 20.4%, respectively, in Spain in 2021. The high prevalence of canine obesity is expected to increase the surgical procedures requiring anesthesia, thereby boosting market growth.
  • Furthermore, an article published in the Journal of Animal Science in July 2021 reported that osteoarthritis (OA) affects about 20% of all adult dogs and over 90% of dogs above five years of age in North America every year. The high burden of the disease requires the use of anesthesia during surgical treatment, thereby propelling the market growth.
  • The strategic initiatives adopted by key market players, such as product launches, approvals, and partnerships, are driving the market growth. For instance, in April 2021, Shenzhen Mindray Animal Medical Technology Co., Ltd. launched its new veterinary anesthesia device called Veta 5 or Veta 3. The product launches are anticipated to propel the market growth.
  • However, the high cost of anesthesia machines will likely impede the market growth.

Veterinary Anesthesia Market Trends

Companion Segment is Expected to Hold a Significant Market Share Over the Forecast Period

  • The companion animal segment is expected to hold a significant market share owing to the increasing prevalence of chronic diseases, rise in pet adoption, and rising pet insurance globally.
  • According to the People's Dispensary for Sick Animals (PDSA) animal wellbeing June 2021 report, 2 million people in the United Kingdom adopted a pet between March 2020 to May 2021. Of these pets, 10% were dogs, 8% were cats, and 13% were rabbits. Also, according to Der Deutsche Heimtiermarkt, 47% of the households in Germany had pets in 2021.
  • Additionally, there were 34.7 million pets in the country, including decorative birds, small animals, and dogs and cats. The number of cats adopted was higher in Germany than in dogs, as 16.7 million cats live in 26% of German households compared to 10.3 million dogs in 21% of households. Such a high rate of pet adoption and population in different countries has increased the focus on the healthcare of animals. This has increased the incidences of veterinary diagnostics, thus increasing the demand for anesthesia required for treating chronic diseases, thereby boosting the market.
  • Furthermore, according to the American Pet Products Association (APPA), it was estimated that in 2021 around USD 109.6 billion was spent on pets in the United States, an increase of approximately 6% from the previous year. The region's increasing pet adoption rate is also forcing more people to pay attention to the availability of pet insurance. Hence, pet owners are spending more on pet health care. This is opening up possibilities for the creation and availability of advanced and effective anesthesia for the effective treatment of animals, which is expected to drive market growth over the coming years.
  • Besides, the strategic initiatives adopted by key players, such as product launches and approvals, fuel the segment growth. For instance, in January 2022, Dechra Pharmaceuticals acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant inhalation anesthesia solutions from Halocarbon Life Sciences, used for animal surgeries. These developments are projected to propel the segment's growth.

North America is Expected to Hold a Significant Market Share Over The Forecast Period.

  • North America is expected to hold a significant share of the veterinary anesthesia market due to increased awareness about animal health and ongoing technological innovations.
  • The increasing number of pet insurance in the region is expected to increase the market growth. For instance, according to the 2022 statistics published by the Insurance Information Institute, it has been observed that in the United States, 3.9 million pets were insured at the end of 2021, with an increase of 20% compared to 2020. In addition, California (19.3%), New York (8.4%), and Florida (6.1%) were the three states with the highest percentage of insured pets in 2021.
  • Also, it has been observed that in Canada 432,533 pets were insured at the end of 2021, with an increase of 22.7% compared to 2020. Also, Ontario (38.9%), British Columbia (20.3%), and Alberta (18.9%) were the three states with the highest percentage of insured pets in 2021. The rising number of pet insurance in the region is also expected to increase the market growth.
  • Furthermore, the research and development activities of various market players to develop effective veterinary anesthesia, product launches, approvals, and partnerships are anticipated to boost the market growth. For instance, in April 2022, Respirair Global collaborated with Dechra United States for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. The partnership aims to expand veterinary anesthesia and develop technologically advanced products. Such developments are anticipated to boost the market growth in the region during the analysis period.

Veterinary Anesthesia Market Competitor Analysis

The veterinary anesthesia market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies with major or significant market shares. Some key players are JD Medical Dist. Co. Inc., Kent Scientific Corporation, Midmark Corporation, Mindray Medical International Limited, Patterson Scientific, ICU Medical, Inc, Supera Anesthesia Innovations, Tecnologia Veterinaria y Medica, S.L, Dispomed Ltd., DRE Veterinary, Vetland Medical Sales & Services, LLC, Avante Health Solutions, Prunus Medical, and Dispomed Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Chronic Diseases And Associated Surgical Procedures
    • 4.2.2 Technological Advancements in Veterinary Anesthesia
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Anesthesia Machines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 On Trolley
    • 5.1.2 Wall Mounted
    • 5.1.3 Table top
  • 5.2 By Animals
    • 5.2.1 Companion
    • 5.2.2 Livestock
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 JD Medical Dist. Co. Inc.
    • 6.1.2 Kent Scientific Corporation
    • 6.1.3 Midmark Corporation
    • 6.1.4 Mindray Medical International Limited
    • 6.1.5 Patterson Scientific
    • 6.1.6 ICU Medical, Inc.
    • 6.1.7 Supera Anesthesia Innovations
    • 6.1.8 Tecnologia Veterinaria y Medica, S.L
    • 6.1.9 Vetland Medical Sales & Services, LLC
    • 6.1.10 Avante Health Solutions
    • 6.1.11 Dispomed Ltd.
    • 6.1.12 Prunus Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS